Topical Doxycycline Monohydrate Hydrogel (NANODOX®) 1% targeting proteases/PAR2 pathway is a novel therapeutic for Atopic Dermatitis
| Image |  |
|---|---|
| Description | scientific article published on 30 September 2020 |
| Author/s |
author: Anna De Benedetto |
| Publication date | September 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |